UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: genomics

8 Free Tools for Genetic Engineers, Molecular and Synthetic Biologists

Having a powerful set of tools is essential in life science research so we’ve compiled the best free platforms for genetic engineers, molecular and synthetic biologists.

Read More

Are smaller biobanks still relevant in the era of 500,000 plus cohorts?

Shona Kerr, MRC Human Genetics Unit, writes:

Large-scale national cohorts and biobanks, linked to detailed genomic, phenotypic and clinical data, are currently being created and developed through investment from a large number of governments worldwide. These data-rich resources are exemplified by the 500,000 research volunteers in the UK Biobank, a cohort established primarily to investigate the genetic and lifestyle determinants of middle and later life diseases. Now it is accessible by all health researchers worldwide and the UK Biobank is supporting an unprecedented range of novel insights into the biology of disease, from varicose veins to lifespan.

Read More

Exploring the Orphan Crop: Pearl Millet

As an awardee of Global Engage’s Early Career Research grant, we are pleased to announce that Ambika Dudhate will be presenting her research about the drought tolerance in pearl millet in detail at the 6th Plant Genomics and Gene Editing Congress: Europe. It will be a great opportunity to discuss the topic on a large platform.

Read More

Is Palm Oil Sustainable for People?

Palm oil belongs to Elaeis, which is the only genus of Arecaceae family that produces edible oil. The current commercial planting is mainly E. guineensis, (Jacq.) originating from West Africa, selected due to its yield superiority. The cultivations occur throughout the tropical belt, especially in Southeast Asia, Africa and South America. To date, palm oil has become the most important oil crop in the world, accounting for 37% of global vegetable oil production. However, palm oil sustainability is always debated. Is palm oil really sustainable for people? To answer this, some facts are worth pondering.

Read More

Cancer Therapy in the Genomic Era: Barriers and Distractions

Recent step change advances in sequencing technologies have delivered a near-complete lexicon of genomic cancer drivers. In parallel, progress in synthetic chemistry has facilitated the assembly of a broad armamentarium of molecularly-targeted therapies. However, whilst immunotherapy agents have produced notable benefits for subgroups of patients, the impact of molecularly-targeted therapies have been relatively modest.

Further unlocking the undeniable power of genomics in cancer will involve both the systematic removal of barriers and the avoidance of distractions that obscure progress. Both of which are discussed here.

Read More

Presentation Slide Release: Strategies and Technologies to Deliver Precision Medicine

Presented at the 4th Global Precision Medicine & Biomarkers Leader Summit, these slides are now available to download and share with your colleagues.

Read More

CRISPR: From Early Discoveries to Applications in Plant Science

The discovery of CRISPR happened by accident in 1987. First applied in mammalian cells in 2013, a year later it was applied to plant cells. Our timeline highlights the milestones of this novel technology until its most recent developments and applications in plant science.

Read More

The future of precision medicine

Unreasonable cost of trial-and-error medicine means precision medicine is imperative for targeted therapies

Rising pressures to decrease healthcare cost globally, the emergence of value-based reimbursement models and healthcare digitisation trends are transitioning the medication model from ‘one-size-fits-all’ to stratified and outcome based targeted therapies.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive